FDA approval for Lenmeldy (atidarsagene autotemcel), to treat early-onset metachromatic leukodystrophy – Orchard Therapeutics
– Orchard Therapeutics, recently acquired by Kyowa Kirin with the goal of accelerating the delivery of new gene therapies to patients around the globe, announced the FDA has… read more.
